Breaking News Instant updates and real-time market news.

ALLO

Allogene Therapeutics

$28.86

-0.03 (-0.10%)

, DOCU

DocuSign

$68.75

1.965 (2.94%)

10:20
11/04/19
11/04
10:20
11/04/19
10:20

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Allogene Therapeutics (ALLO) initiated with a Buy at Canaccord. 2. DocuSign (DOCU) initiated with an Outperform at Evercore ISI. 3. Cloudflare (NET) initiated with an Overweight at Piper Jaffray. 4. BioNTech (BNTX) initiated with a Buy at Canaccord. 5. Benefitfocus (BNFT) initiated with a Buy at Compass Point. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ALLO

Allogene Therapeutics

$28.86

-0.03 (-0.10%)

DOCU

DocuSign

$68.75

1.965 (2.94%)

NET

Cloudflare

$17.05

0.26 (1.55%)

BNFT

Benefitfocus

$24.65

1.54 (6.66%)

TRGP

Targa Resources

$41.00

0.895 (2.23%)

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 19

    Nov

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 16

    Dec

ALLO Allogene Therapeutics
$28.86

-0.03 (-0.10%)

11/04/19
ADAM
11/04/19
INITIATION
Target $36
ADAM
Buy
Allogene Therapeutics initiated with a Buy at Canaccord
Canaccord analyst John Newman initiated coverage of Allogene Therapeutics with a Buy rating and $36 price target.
08/09/19
BTIG
08/09/19
INITIATION
Target $37
BTIG
Buy
Allogene Therapeutics initiated with a Buy at BTIG
BTIG analyst Amanda Murphy initiated Allogene Therapeutics with a Buy rating and a price target of $37 as part of her broader research note on CAR-T cell therapy names developing "off-the-shelf" engineered cell therapeutics for oncology. The analyst notes the company is "well capitalized" with $650M in cash and equivalents with the upcoming catalysts that include the "advancement of UCART19 to potential registrational trials expected in 2020 and the presentation of initial data from the Phase 1 portion of the ongoing ALPHA trial."
08/09/19
BTIG
08/09/19
INITIATION
BTIG
Buy
Allogene Therapeutics initiated with a Buy at BTIG
06/05/19
ROTH
06/05/19
INITIATION
Target $26
ROTH
Neutral
Allogene Therapeutics initiated with a Neutral at Roth Capital
Roth Capital analyst Tony Butler started Allogene Therapeutics with a Neutral rating and $26 price target. Allogene has a "strong team, a strong platform, and access to significant resources to continue development efforts," Butler tells investors in a research note. However, he believes the market has "somewhat priced" these into the stock at current levels.
DOCU DocuSign
$68.75

1.965 (2.94%)

10/02/19
RBCM
10/02/19
NO CHANGE
Target $80
RBCM
Outperform
DocuSign price target raised to $80 from $75 at RBC Capital
RBC Capital analyst Alex Zukin raised his price target on DocuSign to $80 and kept his Outperform rating after hosting meetings with its CFO Mike Sheridan. The analyst notes that after a "strong" Q2 reported last month, the discussion contained "good news" around the company's business fundamentals, demand, growth, and competition, giving him greater confidence in DocuSign's ability to top expectations over the short and long term.
10/17/19
DADA
10/17/19
NO CHANGE
Target $79
DADA
Buy
DocuSign price target raised to $79 from $63 at DA Davidson
DA Davidson analyst Rishi Jaluria raised his price target on DocuSign (DOCU) to $79 and kept his Buy rating after hosting a meeting with its management. The analyst notes the discussions indicated that the company's early Contract Lifecycle Management sales traction is "solid" and should become a larger part of its business. Jaluria adds that while Adobe (ADBE) remains the company's primary competitor, its competitive pressure is "smaller" and growing slower. The analyst further states that DocuSign's international opportunity outside of the English-speaking G20 remains early but is still compelling.
11/04/19
EVER
11/04/19
INITIATION
Target $80
EVER
Outperform
DocuSign initiated with an Outperform at Evercore ISI
Evercore ISI analyst Kirk Materne initiated coverage of DocuSign with an Outperform rating and $80 price target.
10/16/19
WEDB
10/16/19
NO CHANGE
Target $80
WEDB
Outperform
DocuSign price target raised to $80 from $65 at Wedbush
Wedbush analyst Daniel Ives raised his price target for DocuSign (DOCU) to $80 from $65 saying that based on his positive Q3 checks, he believes the company is continuing to see strength in the field and is still in the early innings of capitalizing on an expanding deal pipeline both domestically as well as internationally. Further, the analyst things the brand awareness of DocuSign is "unparalleled in the market" from what he hears from customers/partners and has enabled the company to fend off potential competition thus far from all angles including Adobe (ADBE), which remains the biggest competitive/Street worry with "the bark being a lot worse than the bite."
NET Cloudflare
$17.05

0.26 (1.55%)

11/04/19
PIPR
11/04/19
INITIATION
Target $20
PIPR
Overweight
Cloudflare initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst James Fish initiated coverage of Cloudflare with an Overweight rating and $20 price target. The analyst views the current consensus estimates for Cloudflare as "very conservative" and believes the company's platform is "differentiated enough over the medium-term."
10/08/19
BTIG
10/08/19
INITIATION
Target $20
BTIG
Buy
Cloudflare initiated with a Buy at BTIG
BTIG analyst Edward Parker initiated Cloudflare with a Buy rating and a price target of $20, saying the company offers a "rare opportunity" within infrastructure software as an "innovator" in the Content Delivery Network market. The analyst is positive on Cloudflare's ability to leverage a single software stack on "top of scale-out commodity hardware", which has supported its relative margin outperformance. Parker adds that the company's ability to maintain a best-in-class margin profile is "impressive" given its status as a price aggressor and the "subsidization" of its large user base. The analyst further notes that Cloudflare's position as a early-mover on a "significant architectural re-think in IT" warrants its premium valuation within the "disrupting SaaS vendors" category.
10/08/19
NEED
10/08/19
INITIATION
Target $22
NEED
Buy
Cloudflare initiated with a Buy at Needham
Needham analyst Alex Henderson initiated Cloudflare with a Buy rating and a price target of $22. The analyst is positive on the company's "superb" technology intended to improve performance, security and programmability across the internet. Henderson adds that Cloudflare's cloud-driven business model offers "broad relevance" to major trends in the economy, including a digital transformation to the cloud, lowered latency required by cloud applications, and improved connection security. The analyst contends that the company can sustain a revenue growth of 30%-40% per year over the next 3-5 years while expanding its margins and increasing its cash flows.
10/08/19
10/08/19
INITIATION
Target $23

Outperform
Oppenheimer bullish on Cloudflare, initiates with an Outperform
As previously reported, Oppenheimer analyst Shaul Eyal started coverage of Cloudflare with an Outperform rating and $23 price target. The analyst views Cloudflare as a market disruptor capable of displacing many legacy providers within the categories it operates in. Through 2021, Eyal expects Cloudflare to operate in growth mode with year over year revenue growth at or above 30%.
BNFT Benefitfocus
$24.65

1.54 (6.66%)

11/04/19
COMP
11/04/19
INITIATION
Target $37
COMP
Buy
Benefitfocus initiated with a Buy at Compass Point
Compass Point initiated coverage of Benefitfocus with a Buy rating and $37 price target.
11/04/19
COMP
11/04/19
INITIATION
Target $37
COMP
Buy
Compass Point starts Benefitfocus at Buy, sees 'compelling opportunity'
As previously reported, Compass Point analyst Marshall Senk initiated coverage of Benefitfocus with a Buy rating and $37 price target. He sees the shares presenting investors with a "compelling opportunity" as he believes the company has begun to reach a turning point in its go to market pivot following a challenging transition over the past several quarters and he thinks its strong new lives additions can lead to revenue acceleration in 2020.
08/07/19
CANT
08/07/19
NO CHANGE
Target $47
CANT
Overweight
Benefitfocus price target lowered to $47 from $60 at Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper lowered his price target for Benefitfocus to $47 from $60 after the company reduced its 2019 full year revenue and adjusted EBITDA guidance. The primary reason for the reduction is related to product mix shift on Benefit Place and larger contracts, both of which delay revenue recognition, says the analyst. Halper, however, remains optimistic about the company's evolution to a platform model and its long-term growth outlook. He keeps an Overweight rating on Benefitfocus.
07/29/19
WEDB
07/29/19
NO CHANGE
Target $40
WEDB
Outperform
Benefitfocus price target lowered to $40 from $52 at Wedbush
Wedbush analyst Daniel Ives lowered his price target for Benefitfocus to $40 from $52 to reflect a lower multiple which he believes "clearly is justified in light of recent struggles." The analyst reiterates an Outperform rating on the shares, citing his belief the company's business model can be turned around over the next year with a benefits growth opportunity abound among carriers and enterprises.
TRGP Targa Resources
$41.00

0.895 (2.23%)

10/08/19
BARD
10/08/19
NO CHANGE
Target $49
BARD
Outperform
Targa Resources price target lowered to $49 from $67 at Baird
Baird analyst Ethan Bellamy lowered his price target on Targa Resources to $49 from $67 but he believes its Q3 results could be an inflection point for the company as capex is expected to slow and free cash flow creeps toward positive on the backs of Grand Prix and Gulf Coast Express. Bellamy maintained his Outperform rating on Targa Resources shares.
10/11/19
STFL
10/11/19
DOWNGRADE
Target $41
STFL
Hold
Targa Resources downgraded to Hold from Buy at Stifel
Stifel analyst Selman Akyol downgraded Targa Resources to Hold from Buy with an unchanged price target of $41. The analyst continues to view Targa's asset favorably given the company recently placed its Grand Prix NGL pipeline in service. However, Akyol believes current valuation levels reflect this. Further, Targa Resources has less near-term financial flexibility compared to its large cap peers, contends the analyst.
10/07/19
WELS
10/07/19
DOWNGRADE
Target $43
WELS
Market Perform
Targa Resources downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Michael Blum downgraded Targa Resources to Market Perform from Outperform with a price target of $43, down from $45. The analyst cites his more conservative outlook for natural gas liquids pricing for the downgrade. He now forecasts a 2020 NGL price of 58c per gallon, down from a prior estimate of 69c. He says that across his coverage universe, Targa Resources has the most direct exposure to NGL prices. A challenging NGL price environment could partially offset the benefits of Targa Resources' large scale project ramp and reduced capex, Blum tells investors in a research note.
11/04/19
PIPR
11/04/19
INITIATION
Target $43
PIPR
Neutral
Targa Resources initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Pearce Hammond initiated coverage of Targa Resources with a Neutral rating and $43 price target. While impressed with the progress the company has made over the past few years, the analyst says it will take time for this progress to fully materialize as he does not anticipate meaningful free cash flow generation until 2021.

TODAY'S FREE FLY STORIES

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

, CMCSA

Comcast

$43.59

0.57 (1.33%)

07:44
12/14/19
12/14
07:44
12/14/19
07:44
Periodicals
Berkshire, Anthem among Barron's top 10 stock picks for 2020 »

Barron's has…

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

RDS.B

Royal Dutch Shell

$57.41

-0.19 (-0.33%)

RDS.A

Royal Dutch Shell

$57.44

-0.32 (-0.55%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

VIAC

ViacomCBS

$38.62

0.83 (2.20%)

ANTM

Anthem

$284.14

-0.405 (-0.14%)

DELL

Dell Technologies

$49.39

-0.11 (-0.22%)

GOOG

Alphabet

$1,348.07

-2.09 (-0.15%)

GOOGL

Alphabet Class A

$1,347.11

-1.4 (-0.10%)

UHAL

Amerco

$360.28

7.57 (2.15%)

UTX

United Technologies

$148.99

-0.5 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Feb

PCG

PG&E

$11.26

-0.49 (-4.17%)

07:38
12/14/19
12/14
07:38
12/14/19
07:38
Hot Stocks
California Governor says PG&E restructuring plan 'falls woefully short' »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

MYGN

Myriad Genetics

$25.58

0.58 (2.32%)

07:31
12/14/19
12/14
07:31
12/14/19
07:31
Hot Stocks
Myriad Genetics says study validates polygenic risk score for breast cancer »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPC

Tutor Perini

$15.73

-0.17 (-1.07%)

07:30
12/14/19
12/14
07:30
12/14/19
07:30
Hot Stocks
Tutor Perini 'disappointed,' will appeal jury verdict in SR 99 Alaskan Way case »

Tutor Perini released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

, BD

Budget Group

$0.00

(0.00%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
European Society for Medical Oncology to hold a conference »

ESMO Immuno-Oncology…

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

BD

Budget Group

$0.00

(0.00%)

IDRA

Idera Pharmaceuticals

$1.59

-0.05 (-3.05%)

MRK

Merck

$89.18

0.84 (0.95%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

NKTR

Nektar

$21.28

-0.53 (-2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ATNX

Athenex

$14.56

-2.38 (-14.05%)

, MRK

Merck

$89.18

0.84 (0.95%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Society of Surgical Oncology to hold a symposium »

San Antonio Breast Cancer…

ATNX

Athenex

$14.56

-2.38 (-14.05%)

MRK

Merck

$89.18

0.84 (0.95%)

ONCS

OncoSec

$2.00

-0.39 (-16.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

, CRON

Cronos Group

$7.28

-0.03 (-0.41%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
MJBizDaily to hold a conference »

Marijuana Business…

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

CRON

Cronos Group

$7.28

-0.03 (-0.41%)

NFX

Newfield Exploration

$0.00

(0.00%)

CGC

Canopy Growth

$20.69

-0.455 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDSI

BioDelivery Sciences

$6.40

-0.065 (-1.01%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
BioDelivery Sciences management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

, LEA

Lear

$129.43

-0.84 (-0.64%)

17:22
12/13/19
12/13
17:22
12/13/19
17:22
Hot Stocks
Grand Canyon, Lear to replace Oasis, Southwestern in S&P 400 at open on 12/23 »

Grand Canyon Education…

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

RTN

Raytheon

$217.31

-0.93 (-0.43%)

17:20
12/13/19
12/13
17:20
12/13/19
17:20
Hot Stocks
Raytheon awarded $123.53M Navy contract modification »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.